ISM (Intisari Sains Medis) : Jurnal Kedokteran
Vol. 12 No. 1 (2021): (Available online : 1 April 2021)

Dramatic improvement in severe-critical COVID-19 patient after tocilizumab administration: a clinical experience

Yesicha Kurniawati (Intern of Pulmonology and Respiratory Medicine Department, Wangaya Regional General Hospital, Denpasar, Bali, Indonesia)
Kadek Surya Atmaja (Intern of Pulmonology and Respiratory Medicine Department, Wangaya Regional General Hospital, Denpasar, Bali, Indonesia)
Ketut Suryana (Internist of Internal Medicine Department, Wangaya Regional General Hospital, Denpasar, Bali, Indonesia)
Wayan Wahyu Semara Putra (Pulmonologist of Pulmonology and Respiratory Medicine Department, Wangaya Regional General Hospital, Denpasar, Bali, Indonesia)



Article Info

Publish Date
30 Apr 2021

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in coronavirus disease 2019 (COVID-19) involve so many inflammatory cytokines, especially Interleukin-6 (IL-6). The usage of tocilizumab as an anti-IL-6 receptor antibody had been approved as COVID-19 medication.Case Presentation: This article reports a 51-year-old woman diagnosed with severe-critical COVID-19. The patient made significant progress after tocilizumab administration. The patient was hospitalized for 14 days before being discharged.Conclusion: Tocilizumab administration showed a significant improvement in COVID-19 patients.  However, further investigations are needed to explain this further.

Copyrights © 2021






Journal Info

Abbrev

ism

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Description

Intisari Sains Medis is published by Medical Scientific Community, Indonesia. Intisari Sains Medis is an international, multidisciplinary, peer-reviewed, open access journal accepts papers for publication in all aspects of Science Digest, Medical Research Development, Research Medical Field and ...